Kjcef Injection is administered for treatment of acute otitis media, respiratory system infections, UTI, & chronic gonorrhea. It has been formulated using ceftriaxone & sulbactam as active compounds. Belongs to cephalosporin drug class, this injection shows activity against both gram positive & gram negative bacteria. Kjcef Injection works by binding to penicillin binding proteins and inhibiting synthesis of peptidoglycan layer of bacterial cell wall. It also inhibits beta lactamase of microorganisms and prevents their resistance from antibiotics. This injection can be administered via intramuscular & intravenous routes with elimination half life of 5.8 to 8.7 hours.